155 related articles for article (PubMed ID: 30457095)
1. Case Report: Central Nervous System Strongyloidiasis: Two Cases Diagnosed Antemortem.
Tam J; Schwartz KL; Keystone J; Dimitrakoudis D; Downing M; Krajden S
Am J Trop Med Hyg; 2019 Jan; 100(1):130-134. PubMed ID: 30457095
[TBL] [Abstract][Full Text] [Related]
2. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
3. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
4. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
5. [Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection].
Guevara Miranda J; Guzmán Rojas P; Espinoza-Ríos J; Mejía Cordero F
Rev Gastroenterol Peru; 2017; 37(2):169-172. PubMed ID: 28731999
[TBL] [Abstract][Full Text] [Related]
6. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Strongyloidiasis.
Mileo Bacelar Guerreiro F; Tavares Sodré C; Brandão Pavan L; Feijó Barroso P; Carvalho Quintella D; Cuzzi T; Ramos-E-Silva M
Acta Dermatovenerol Croat; 2018 Dec; 26(4):333-336. PubMed ID: 30665485
[TBL] [Abstract][Full Text] [Related]
9. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
Lambertucci JR; Leão FC; Barbosa AJ
Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
[No Abstract] [Full Text] [Related]
10. Case report: Antemortem diagnosis of central nervous system strongyloidiasis.
Meltzer RS; Singer C; Armstrong D; Mayer K; Knapper WH
Am J Med Sci; 1979; 277(1):91-8. PubMed ID: 426003
[TBL] [Abstract][Full Text] [Related]
11. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host.
Gordon SM; Gal AA; Solomon AR; Bryan JA
J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):255-9. PubMed ID: 8040411
[TBL] [Abstract][Full Text] [Related]
12. Duodenal obstruction due to
Harshan M; Niyas VKM; Arjun R
Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
[No Abstract] [Full Text] [Related]
13. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
14. Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia.
Alpern JD; Arbefeville SS; Vercellotti G; Ferrieri P; Green JS
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860061
[TBL] [Abstract][Full Text] [Related]
15. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
16. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
[TBL] [Abstract][Full Text] [Related]
17. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
18. Image of the month: Target the bugs:
Hokama A; Kishimoto K
Clin Med (Lond); 2021 Mar; 21(2):e239-e240. PubMed ID: 33762395
[TBL] [Abstract][Full Text] [Related]
19. A 56-year-old woman with rash, paralytic ileus, and massive gastrointestinal bleeding.
Seas C; Legua P
Clin Infect Dis; 2009 Oct; 49(7):1094-5, 1132-3. PubMed ID: 19739959
[No Abstract] [Full Text] [Related]
20. [Disseminated infection due to strongyloides stercoralis in AIDS patients. A report of 2 cases].
Trione N; Corti M; Castello T; Abuin JC; Bellegarde E
Acta Gastroenterol Latinoam; 2001; 31(5):399-402. PubMed ID: 11873668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
